{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-159676","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2022-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.733737+00:00","generated_at":"2026-06-25T07:09:07.310743+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Biodesix stockholders elect two Class II directors and ratify KPMG as auditor","bullets":["Matthew Strobeck, Ph.D. and Charles Watts, M.D. elected as Class II directors (23.1M votes for each).","KPMG LLP ratified as independent auditor for FY2022 with 26.5M votes for, 14,941 against.","31,839,317 shares outstanding as of record date March 25, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-159676","json":"https://secwatch.observer/filing/0001193125-22-159676.json","markdown":"https://secwatch.observer/filing/0001193125-22-159676.md","text":"https://secwatch.observer/filing/0001193125-22-159676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000119312522159676/0001193125-22-159676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000119312522159676/d323176d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T07:09:07.310743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}